Mistake 3: reducing the dose when side effects occur instead of holding steady When nausea or other GI symptoms appear after a dose increase, some researchers immediately drop back to the previous dose
Within seconds, I was moved to the next screen
Important issues to review include nausea, vomiting, constipation, diarrhea, reflux, hydration status, protein intake, muscle preservation, diabetes medications, gallbladder symptoms, kidney function, history of pancreatitis, thyroid and family history considerations, and long-term maintenance strategy
Eligibility for a GLP-1 medication depends on a Service Members diagnosis, prior authorization, and/or medical necessity
Thank you
Cochrane Metabolic and Endocrine Disorders Group, ed